• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S1P 裂解酶对胸腺迁出和致癌性炎症信号的调控。

S1P Lyase Regulation of Thymic Egress and Oncogenic Inflammatory Signaling.

机构信息

Department of Biochemistry, All India Institute of Medical Sciences (AIIMS) Bhopal, Madhya Pradesh 462020, India.

Children's Hospital Oakland Research Institute and UCSF Benioff Children's Hospital Oakland, 5700 Martin Luther King Jr. Way, Oakland, CA 94609, USA.

出版信息

Mediators Inflamm. 2017;2017:7685142. doi: 10.1155/2017/7685142. Epub 2017 Dec 3.

DOI:10.1155/2017/7685142
PMID:29333002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5733215/
Abstract

Sphingosine-1-phosphate (S1P) is a potent lipid signaling molecule that regulates pleiotropic biological functions including cell migration, survival, angiogenesis, immune cell trafficking, inflammation, and carcinogenesis. It acts as a ligand for a family of cell surface receptors. S1P concentrations are high in blood and lymph but low in tissues, especially the thymus and lymphoid organs. S1P chemotactic gradients are essential for lymphocyte egress and other aspects of physiological cell trafficking. S1P is irreversibly degraded by S1P lyase (SPL). SPL regulates lymphocyte trafficking, inflammation and other physiological and pathological processes. For example, SPL located in thymic dendritic cells acts as a metabolic gatekeeper that controls the normal egress of mature T lymphocytes from the thymus into the circulation, whereas SPL deficiency in gut epithelial cells promotes colitis and colitis-associated carcinogenesis (CAC). Recently, we identified a complex syndrome comprised of nephrosis, adrenal insufficiency, and immunological defects caused by inherited mutations in human , the gene encoding SPL. In the present article, we review current evidence supporting the role of SPL in thymic egress, inflammation, and cancer. Lastly, we summarize recent progress in understanding other SPL functions, its role in inherited disease, and SPL targeting for therapeutic purposes.

摘要

鞘氨醇-1-磷酸(S1P)是一种有效的脂质信号分子,调节多种生物功能,包括细胞迁移、存活、血管生成、免疫细胞迁移、炎症和癌症发生。它作为细胞表面受体家族的配体发挥作用。S1P 浓度在血液和淋巴中较高,但在组织中较低,特别是在胸腺和淋巴器官中。S1P 趋化梯度对于淋巴细胞渗出和其他生理细胞迁移方面至关重要。S1P 被 S1P 裂解酶(SPL)不可逆地降解。SPL 调节淋巴细胞迁移、炎症和其他生理和病理过程。例如,位于胸腺树突状细胞中的 SPL 作为代谢守门员,控制成熟 T 淋巴细胞从胸腺正常流出到循环中,而肠道上皮细胞中的 SPL 缺乏会促进结肠炎和结肠炎相关的癌症发生(CAC)。最近,我们鉴定了一种由人类 SPL 基因编码的 SPL 遗传突变引起的肾病、肾上腺功能不全和免疫缺陷的复杂综合征。在本文中,我们综述了支持 SPL 在胸腺迁出、炎症和癌症中的作用的现有证据。最后,我们总结了对 SPL 其他功能、其在遗传性疾病中的作用以及 SPL 靶向治疗目的的最新认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b88/5733215/772e44f4eee2/MI2017-7685142.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b88/5733215/2eed690d9ae7/MI2017-7685142.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b88/5733215/9c137dd77312/MI2017-7685142.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b88/5733215/bd0e95888c92/MI2017-7685142.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b88/5733215/772e44f4eee2/MI2017-7685142.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b88/5733215/2eed690d9ae7/MI2017-7685142.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b88/5733215/9c137dd77312/MI2017-7685142.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b88/5733215/bd0e95888c92/MI2017-7685142.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b88/5733215/772e44f4eee2/MI2017-7685142.004.jpg

相似文献

1
S1P Lyase Regulation of Thymic Egress and Oncogenic Inflammatory Signaling.S1P 裂解酶对胸腺迁出和致癌性炎症信号的调控。
Mediators Inflamm. 2017;2017:7685142. doi: 10.1155/2017/7685142. Epub 2017 Dec 3.
2
Dendritic cell sphingosine-1-phosphate lyase regulates thymic egress.树突状细胞鞘氨醇-1-磷酸裂解酶调节胸腺输出。
J Exp Med. 2016 Nov 14;213(12):2773-2791. doi: 10.1084/jem.20160287. Epub 2016 Oct 17.
3
Lyase to live by: sphingosine phosphate lyase as a therapeutic target.依赖裂合酶生存:神经酰胺磷酸裂合酶作为治疗靶点。
Expert Opin Ther Targets. 2009 Aug;13(8):1013-25. doi: 10.1517/14728220903039722.
4
S1P lyase in thymic perivascular spaces promotes egress of mature thymocytes via up-regulation of S1P receptor 1.胸腺血管周围间隙中的S1P裂解酶通过上调S1P受体1促进成熟胸腺细胞的迁出。
Int Immunol. 2014 May;26(5):245-55. doi: 10.1093/intimm/dxt069. Epub 2013 Dec 16.
5
The low down on sphingosine-1-phosphate lyase as a regulator of thymic egress.鞘氨醇-1-磷酸裂解酶作为胸腺输出调节因子的相关研究
J Immunol Sci. 2017;1(1):1-8. doi: 10.29245/2578-3009/2018/1.1103. Epub 2017 Dec 6.
6
Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs.鞘氨醇-1-磷酸裂解酶下调通过STAT3激活的微小RNA促进结肠癌发生。
J Clin Invest. 2014 Dec;124(12):5368-84. doi: 10.1172/JCI74188. Epub 2014 Oct 27.
7
Sphingosine-1-Phosphate Lyase Inhibition Alters the S1P Gradient and Ameliorates Crohn's-Like Ileitis by Suppressing Thymocyte Maturation.鞘氨醇-1-磷酸酶抑制作用通过抑制胸腺细胞成熟来改变 S1P 梯度并改善克罗恩样回肠炎。
Inflamm Bowel Dis. 2020 Jan 6;26(2):216-228. doi: 10.1093/ibd/izz174.
8
Downregulation of S1P Lyase Improves Barrier Function in Human Cerebral Microvascular Endothelial Cells Following an Inflammatory Challenge.S1P 裂解酶下调可改善炎症挑战后人脑血管内皮细胞的屏障功能。
Int J Mol Sci. 2020 Feb 13;21(4):1240. doi: 10.3390/ijms21041240.
9
Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.通过抑制S1P裂解酶和破坏S1P梯度实现淋巴细胞隔离。
Science. 2005 Sep 9;309(5741):1735-9. doi: 10.1126/science.1113640.
10
Sphingosine-1-phosphate and immune regulation: trafficking and beyond.鞘氨醇-1-磷酸与免疫调节:运输及其他。
Trends Pharmacol Sci. 2011 Jan;32(1):16-24. doi: 10.1016/j.tips.2010.11.002. Epub 2010 Dec 14.

引用本文的文献

1
Metabolomics as a tool for understanding and treating triple-negative breast cancer.代谢组学作为理解和治疗三阴性乳腺癌的一种工具。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 2. doi: 10.1007/s00210-025-04234-4.
2
Targeting the Sphingosine-1-Phosphate Pathway: New Opportunities in Inflammatory Bowel Disease Management.靶向鞘氨醇-1-磷酸通路:炎症性肠病管理的新机遇。
Drugs. 2024 Oct;84(10):1179-1197. doi: 10.1007/s40265-024-02094-5. Epub 2024 Sep 26.
3
Regulation of cellular and systemic sphingolipid homeostasis.细胞和全身鞘脂稳态的调节。

本文引用的文献

1
Regulation of Immune Cell Migration by Sphingosine-1-Phosphate.鞘氨醇-1-磷酸对免疫细胞迁移的调节
Cell Mol Biol (OMICS). 2015;61(2). Epub 2015 Dec 31.
2
The sphingosine 1-phosphate breakdown product, (2)-hexadecenal, forms protein adducts and glutathione conjugates in vitro.鞘氨醇-1-磷酸的分解产物(2)-十六碳烯醛在体外形成蛋白质加合物和谷胱甘肽共轭物。
J Lipid Res. 2017 Aug;58(8):1648-1660. doi: 10.1194/jlr.M076562. Epub 2017 Jun 6.
3
SGPL1 (sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production.
Nat Rev Mol Cell Biol. 2024 Oct;25(10):802-821. doi: 10.1038/s41580-024-00742-y. Epub 2024 Jun 18.
4
Sphingosine-1-Phosphate as Lung and Cardiac Vasculature Protecting Agent in SARS-CoV-2 Infection.鞘氨醇-1-磷酸在 SARS-CoV-2 感染中作为肺部和心血管系统保护剂。
Int J Mol Sci. 2023 Aug 23;24(17):13088. doi: 10.3390/ijms241713088.
5
Targeting SPHK1/S1PR3-regulated S-1-P metabolic disorder triggers autophagic cell death in pulmonary lymphangiomyomatosis (LAM).靶向 SPHK1/S1PR3 调控的 S-1-P 代谢紊乱可触发肺淋巴管肌瘤病 (LAM) 中的自噬性细胞死亡。
Cell Death Dis. 2022 Dec 21;13(12):1065. doi: 10.1038/s41419-022-05511-3.
6
Potential Serum Biomarkers Associated with Premature Rupture of Fetal Membranes in the First Trimester.孕早期胎膜早破相关的潜在血清生物标志物
Front Pharmacol. 2022 Jul 8;13:915935. doi: 10.3389/fphar.2022.915935. eCollection 2022.
7
Molecular Pharmacology and Novel Potential Therapeutic Applications of Fingolimod.芬戈莫德的分子药理学及新型潜在治疗应用
Front Pharmacol. 2022 Feb 16;13:807639. doi: 10.3389/fphar.2022.807639. eCollection 2022.
8
Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer.微小RNA与鞘氨醇激酶、1-磷酸鞘氨醇及1-磷酸鞘氨醇受体在癌症中的相互作用
Discov Oncol. 2021 Sep 20;12(1):33. doi: 10.1007/s12672-021-00430-9.
9
Review article: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis - a unique therapeutic target in inflammatory bowel disease.综述文章:鞘氨醇 1 磷酸/鞘氨醇 1 磷酸受体轴——炎症性肠病的独特治疗靶点。
Aliment Pharmacol Ther. 2022 Feb;55(3):277-291. doi: 10.1111/apt.16741. Epub 2021 Dec 21.
10
Sphingosine-1-Phosphate Catabolizing Enzymes Predict Better Prognosis in Triple-Negative Breast Cancer Patients and Correlates With Tumor-Infiltrating Immune Cells.鞘氨醇-1-磷酸分解酶预示三阴性乳腺癌患者预后更佳且与肿瘤浸润免疫细胞相关。
Front Mol Biosci. 2021 Jun 21;8:697922. doi: 10.3389/fmolb.2021.697922. eCollection 2021.
SGPL1(鞘氨醇磷酸裂解酶1)通过磷脂酰乙醇胺的产生来调节神经元自噬。
Autophagy. 2017 May 4;13(5):885-899. doi: 10.1080/15548627.2017.1291471.
4
Characterization of cholesterol homeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts reveals a Niemann-Pick disease type C-like phenotype with enhanced lysosomal Ca storage.鞘氨醇-1-磷酸酶缺陷型成纤维细胞中胆固醇稳态的特征表明溶酶体钙储存增强的尼曼-匹克病 C 样表型。
Sci Rep. 2017 Mar 6;7:43575. doi: 10.1038/srep43575.
5
Ceramide synthase 2 facilitates S1P-dependent egress of thymocytes into the circulation in mice.神经酰胺合成酶2促进小鼠胸腺细胞依赖鞘氨醇-1-磷酸(S1P)进入循环系统。
Eur J Immunol. 2017 Apr;47(4):677-684. doi: 10.1002/eji.201646623. Epub 2017 Feb 27.
6
Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications.鞘氨醇-1-磷酸裂解酶SGPL1缺乏与先天性肾病综合征和先天性肾上腺钙化有关。
Hum Mutat. 2017 Apr;38(4):365-372. doi: 10.1002/humu.23192. Epub 2017 Mar 6.
7
Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome.鞘氨醇-1-磷酸裂解酶突变导致原发性肾上腺功能不全和类固醇抵抗性肾病综合征。
J Clin Invest. 2017 Mar 1;127(3):942-953. doi: 10.1172/JCI90171. Epub 2017 Feb 6.
8
Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency.鞘氨醇-1-磷酸裂解酶突变导致肾病伴鱼鳞病和肾上腺功能不全。
J Clin Invest. 2017 Mar 1;127(3):912-928. doi: 10.1172/JCI89626. Epub 2017 Feb 6.
9
Altered Expression of Sphingosine-1-Phosphate Metabolizing Enzymes in Oral Cancer Correlate With Clinicopathological Attributes.口腔癌中鞘氨醇-1-磷酸代谢酶的表达改变与临床病理特征相关。
Cancer Invest. 2017 Feb 7;35(2):139-141. doi: 10.1080/07357907.2016.1272695. Epub 2017 Jan 31.
10
Sphingosine 1-phosphate lyase deficiency causes Charcot-Marie-Tooth neuropathy.鞘氨醇-1-磷酸裂解酶缺乏会导致夏科-马里-图斯神经病变。
Neurology. 2017 Feb 7;88(6):533-542. doi: 10.1212/WNL.0000000000003595. Epub 2017 Jan 11.